Saturday, February 21, 2026
18.4 C
Bengaluru

Pharma – Physician Interactions in the Digital Era

The skill-set required by marketing managers and front-line professionals in the digital era is different.

Indian Pharma companies will have to create hybrid employees, who can be designated as the Digital Task Force (DTF).

Just as STFs were created to create a better perception and improve engagement with specialist doctors, DTF can rebuild relationships with doctors on a new premise of helping them to gain digital advantage to better manage their practice and patients.

DTF must be a team of marketing, sales, medical, training, SFE, digital experts, and others like supply chain specialists to be able to seamlessly cater to customer needs as it emerges.

Something like the highly organized and effective team of commandos, who can tackle situations as they evolve with minimum control, from someone sitting in the comfort of a ‘HO’ cabin.

DTF requires people that have a strong growth mindset and are oriented to be self-directed learners because digital literacy and fluency becomes difficult directly in proportion to the duration spent by a person in the analog world.

For details about MedicinMan 4-Module Workshop – Digital Noise to Digital Voice – https://medicinman.net/2021/10/digital-noise-to-digital-voice-a-4-module-workshop-for-pharma-people/

https://medicinman.net/2021/10/digital-noise-to-digital-voice-a-4-module-workshop-for-pharma-people/

Hot this week

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Topics

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...
spot_img

Related Articles

spot_imgspot_img